Morning Movers: Shell ticks higher after denying interest in BP deal

Stock futures are drifting cautiously higher as the S&P edges close to record highs. The dollar is under pressure amid the worst first-half performance in 50 years, falling to its lowest since early 2022 amid speculation that President Trump may replace Fed Chair Powell before his term ends and markets pricing in over 60 basis points of rate cuts by year-end. Treasury yields, including the 10‑year at 4.27%, have eased across the curve.

Chipmakers and tech continue to lead and stock futures show strength while oil has recovered mildly to about $65-$68, little changed, supported by a holding Israel‑Iran ceasefire, while gold is slightly higher amid currency moves.

In pre-market trading, S&P 500 futures rose 0.28%, Nasdaq futures rose 0.38% and Dow rose 0.22%.

Check out this morning’s top movers from around Wall Street, compiled by The Fly. Also, subscribe to The Fly’s pre-market Fly By if you want to know how the markets will open, which stocks will be moving and why. 

HIGHER –

• Shell (SHEL) up nearly 3% in New York after saying it has not been actively considering making an offer for BP (BP)
• Vor Bio (VOR) up 92% after being granted global rights to commercialize telitacicept and entering $175M private placement

UP AFTER EARNINGS –

• Acuity Brands (AYI) up 10%
• Lindsay (LNN) up 5%
• McCormick (MKC) up 4%
• Walgreens Boots Alliance (WBA) up 1%
• Micron (MU) up 1%

DOWN AFTER EARNINGS –

• Hive Digital (HIVE) down 2%
• Jefferies Financial (JEF) down 2%

LOWER –

• Edgewise Therapeutics (EWTX) down 9% after FDA deemed the CANYON data alone insufficient for an accelerated approval of sevasemten
• Kratos Defense (KTOS) down 7% after 12.987M share secondary offering priced at $38.50 per share